Abstract  Description  Claims  Drawing  Search report  Cited references 

RU105564   [0019] 

Nanoparticle Formulations in Pulmonary Drug Delivery   [0019] 
Aerosol delivery of chemotherapy in an orthotopic model of lung cancer   [0019] 
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers - therapeutic possibilities and technological challenges   [0019] 
The lung as a route for systemic delivery of therapeutic proteins and peptides   [0019] 
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications   [0019] 
The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination   [0019] 
The Lungs as a Portal of Entry for Systemic Drug Delivery   [0019] 
Recent Advances Related to the Systemic Delivery of Therapeutic Molecules by Inhalation   [0019] 
Aerosol Technology   [0019] 
Deposition of Inhaled Particles in the Human Respiratory Tract and Consequences for Regional Targeting in Respiratory Drug Delivery   [0019] 
Lung deposition predictions of airborne particles and the emergence of contemporary diseases Part-I   [0019] 
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles   [0019] 
Inhalation Exposure Systems: Design, Methods and Operation   [0019] 
Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women   [0019] 
Fast onset medications through thermally generated aerosols   [0019] 
Laboratory verification of Aerosol Diffusion Spectrometer and the application to ambient measurements of new particle formation   [0019]